World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Still, the pharma industry is fighting hard to keep it off the table. Nearly 9 in 10 older adults take prescription medication.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

PharmExec

JULY 18, 2023

Pharma giant to serve as Team USA’s partner in prescription medicine and health equity.

Prescription 52

Prescription Medicine Pharma 52

pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. Ipsen’s CVR offer includes $0.30

Biopharma 111

Biopharma Sales Prescription FDA 111

PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen. The impact of the IRA’s price negotiations on payers is mixed, he noted.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Representative Training

JANUARY 29, 2025

While biologics only account for 2% of overall prescriptions, they contribute to 37% of net drug spending [1]. Newer or less prominent manufacturers will struggle the most with these challenges, but there are teams with the experience and tools to overcome these obstacles and get more biosimilars into the pharma market.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

MAY 13, 2024

Many insurers use similar networks for Medicaid and exchange plans, so shifting to an exchange plan is less likely to cause a lapse in coverage or abandonment of prescription drugs or maintenance medications that control chronic conditions.

Insurance 52

Insurance Marketing Healthcare Healthcare 52